3-acetyl-11-KETO-BETA-BOSWELLIC ACID (cas 17019-92-0) decreases the malignancy of taxol resistant human ovarian cancer by inhibiting multidrug resistance (MDR) proteins function

Add time:08/09/2019    Source:sciencedirect.com

ObjectiveRecurrence of ovarian cancer is mainly due to multidrug resistance (MDR). 3-acetyl-11-keto-beta-boswellic acid (AKBA) could reverse the multidrug resistance in human ileocecal adenocarcinoma cells, but whether AKBA could modulate acquired MDR in ovarian cancer needs to be elucidated.

We also recommend Trading Suppliers and Manufacturers of 11-KETO-BETA-BOSWELLIC ACID (cas 17019-92-0). Pls Click Website Link as below: cas 17019-92-0 suppliers

Prev:The first example of a one-step synthesis of 2′-O-acetyl aryl-d
Next:Biotransformation of 11-keto-β-boswellic acid by Cunninghamella blakesleana)